PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule | Ligand Name | Ligand Feature ▲ | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
S-fimbriae (SfaA)
|
Galactosyl sulfatide
|
Sulfoglycosphingolipids
|
Brain endothelial cells
|
Gal(3SO4)(b1-1)Cer
|
Binding
|
||
35S-labeled or 125I-labeled proteins
|
Sulfatide (CSE)
|
Sulfoglycosphingolipids
|
Piglet intestine
|
HSO3(-3)Gal(b1-1)Cer
|
Not Binding
|
||
35S-labeled or 125I-labeled proteins
|
Sulfo-lactosylceramide (SM3)
|
Sulfoglycosphingolipids
|
Piglet intestine
|
HSO3(-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
35S-labeled or 125I-labeled proteins
|
Sulfo-gangliotetraosylceramide (Sulfo-GgO4)
|
Sulfoglycosphingolipids
|
Mouse small intestine
|
HSO3(-3)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
F1C
|
Sulfatide (CSE)
|
Sulfoglycosphingolipids
|
Porcine intestine
|
HSO3(-3)Gal(b1-1)Cer
|
Not Binding
|
||
Unknown
|
Galactosylceramide 6-sulfate
|
Sulfoglycosphingolipids
|
Human colon adenocarcinoma cells (WiDr )
|
Gal(6SO4)(b1-1)Cer
|
Binding
|
||
Unknown
|
Galactosyl sulfatide
|
Sulfoglycosphingolipids
|
Human colon adenocarcinoma cells (WiDr )
|
Gal(3SO4)(b1-1)Cer
|
Binding
|
||
Unknown
|
Sulfated glucuronyl paragloboside
|
Sulfoglycosphingolipids
|
Human colon adenocarcinoma cells (WiDr )
|
GlcA(3SO4)(b1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
Unknown
|
Sulfatide (CSE)
|
Sulfoglycosphingolipids
|
Human meconium
|
HSO3(-3)Gal(b1-1)Cer
|
Not Binding
|
||
Unknown
|
Sulfo-gangliotetraosylceramide (Sulfo-GgO4)
|
Sulfoglycosphingolipids
|
Mouse small intestine
|
HSO3(-3)Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01